These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25732361)

  • 1. Device therapy: High-zone programming of ICDs reduces inappropriate shocks.
    Huynh K
    Nat Rev Cardiol; 2015 Apr; 12(4):193. PubMed ID: 25732361
    [No Abstract]   [Full Text] [Related]  

  • 2. Programming implantable cardioverter-defibrillator therapy zones to high ranges to prevent delivery of inappropriate device therapies in patients with primary prevention: results from the RISSY-ICD (Reduction of Inappropriate ShockS bY InCreaseD zones) trial.
    Cay S; Canpolat U; Ucar F; Ozeke O; Ozcan F; Topaloglu S; Aras D
    Am J Cardiol; 2015 May; 115(9):1235-43. PubMed ID: 25765588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abdominal submuscular implant of subcutaneous implantable cardioverter-defibrillator in a young child.
    Kwok SY; Yam N; Lun KS; Chen RH; Au TW; Yung TC
    Europace; 2018 Sep; 20(FI2):f248. PubMed ID: 29401320
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.
    Lunati M; Proclemer A; Boriani G; Landolina M; Locati E; Rordorf R; Daleffe E; Ricci RP; Catanzariti D; Tomasi L; Gulizia M; Baccillieri MS; Molon G; Gasparini M;
    Europace; 2016 Sep; 18(9):1391-8. PubMed ID: 26826135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
    Friedman PA; McClelland RL; Bamlet WR; Acosta H; Kessler D; Munger TM; Kavesh NG; Wood M; Daoud E; Massumi A; Schuger C; Shorofsky S; Wilkoff B; Glikson M
    Circulation; 2006 Jun; 113(25):2871-9. PubMed ID: 16769912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIMPLEr not to test implantable cardioverter defibrillators?
    Singh JP; Holzmeister J
    Lancet; 2015 Feb; 385(9970):753-5. PubMed ID: 25715990
    [No Abstract]   [Full Text] [Related]  

  • 7. Early experience with the subcutaneous ICD.
    Lambiase PD; Srinivasan NT
    Curr Cardiol Rep; 2014 Aug; 16(8):516. PubMed ID: 24994568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population.
    Buber J; Luria D; Gurevitz O; Bar-Lev D; Eldar M; Glikson M
    Europace; 2014 Feb; 16(2):227-34. PubMed ID: 24108231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.
    Kron J; Sauer W; Schuller J; Bogun F; Crawford T; Sarsam S; Rosenfeld L; Mitiku TY; Cooper JM; Mehta D; Greenspon AJ; Ortman M; Delurgio DB; Valadri R; Narasimhan C; Swapna N; Singh JP; Danik S; Markowitz SM; Almquist AK; Krahn AD; Wolfe LG; Feinstein S; Ellenbogen KA
    Europace; 2013 Mar; 15(3):347-54. PubMed ID: 23002195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual substrate underlying Brugada syndrome and early repolarization syndrome revealed in unusual circadian and seasonal patterns.
    Schwartz BG; Kloner RA; Cannom DS
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):764-5. PubMed ID: 22487225
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE).
    Healey JS; Hohnloser SH; Glikson M; Neuzner J; Mabo P; Vinolas X; Kautzner J; O'Hara G; VanErven L; Gadler F; Pogue J; Appl U; Gilkerson J; Pochet T; Stein KM; Merkely B; Chrolavicius S; Meeks B; Foldesi C; Thibault B; Connolly SJ;
    Lancet; 2015 Feb; 385(9970):785-91. PubMed ID: 25715991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming the defects of a virtue: dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
    Sweeney MO
    Circulation; 2006 Jun; 113(25):2862-4. PubMed ID: 16801472
    [No Abstract]   [Full Text] [Related]  

  • 13. Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment.
    Technol Eval Cent Assess Program Exec Summ; 2010 Nov; 25(2):1-5. PubMed ID: 21638938
    [No Abstract]   [Full Text] [Related]  

  • 14. Iatrogenic Palpitations during Exercise in a Patient with a Dual Chamber Implantable Cardioverter-Defibrillator and Lead Dysfunction.
    Hasegawa K; Miyazaki S; Kaseno K; Tada H
    Int Heart J; 2019 Mar; 60(2):462-465. PubMed ID: 30626767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing patients with ICD shocks and programming tachycardia therapies during acute heart failure syndromes.
    Bradfield J; Tung R; Boyle NG; Shivkumar K
    Heart Fail Rev; 2011 Sep; 16(5):449-56. PubMed ID: 21451976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between detection rate and inappropriate shocks in single versus dual chamber cardioverter-defibrillator--an analysis from the OPTION trial.
    Kolb C; Sturmer M; Babuty D; Sick P; Davy JM; Molon G; Schwab JO; Mantovani G; Wickliffe A; Lennerz C; Semmler V; Siot PH; Reif S
    Sci Rep; 2016 Feb; 6():21748. PubMed ID: 26892534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable Cardioverter Defibrillator Programming Characteristics, Shocked Rhythms, and Survival Among Patients Under Thirty Years of Age.
    Chang PM; Powell BD; Jones PW; Carter N; Hayes DL; Saxon LA
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1183-1190. PubMed ID: 27334356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OptiVol fluid index: does an association with ventricular arrhythmias hold water?
    Sullivan RM; Olshansky B
    J Cardiovasc Electrophysiol; 2011 Mar; 22(3):300-1. PubMed ID: 21091968
    [No Abstract]   [Full Text] [Related]  

  • 19. Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results.
    Auricchio A; Schloss EJ; Kurita T; Meijer A; Gerritse B; Zweibel S; AlSmadi FM; Leng CT; Sterns LD;
    Heart Rhythm; 2015 May; 12(5):926-36. PubMed ID: 25637563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-Month Outcomes in Patients With Implantable Cardioverter-Defibrillators Undergoing Renal Sympathetic Denervation for the Treatment of Refractory Ventricular Arrhythmias.
    Armaganijan LV; Staico R; Moreira DA; Lopes RD; Medeiros PT; Habib R; Melo Neto J; Katz M; Armaganijan D; Sousa AG; Mahfoud F; Abizaid A
    JACC Cardiovasc Interv; 2015 Jun; 8(7):984-90. PubMed ID: 26088516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.